Press Release: Benitec Biopharma Provides -2

Here’s a summary of the most significant insider transactions disclosed on Monday, December 29, 2025.

TOP BUYS

Dolphin Entertainment (NASDAQ:DLPN) saw its Chief Executive Officer William O’Dowd IV purchase 3,600 shares at prices between $1.33 and $1.43, with a reported transaction value of $4,957,200. Following this acquisition, O’Dowd directly owns 416,990 shares and indirectly controls an additional 116,641 shares through his wholly-owned entities Dolphin Entertainment, LLC (54,535 shares) and Dolphin Digital Media Holdings, LLC (62,106 shares).

Benitec Biopharma Inc (NASDAQ:BNTC) received significant investment from Suvretta Capital Management, LLC and related entities, which increased their stake through purchases totaling $1.9 million. The transactions occurred across three trading days (December 23, 26, and 29, 2025) at prices ranging from $12.85 to $13.44 per share. Specifically, Averill Master Fund acquired 122,720 shares (42,600 at $12.85, 14,320 at $13.10, and 65,800 at $13.44), while Averill Madison Master Fund purchased 21,503 shares (7,400 at $12.85, 2,516 at $13.10, and 11,587 at $13.44).

TriplePoint Venture Growth BDC Corp (NASDAQ:TPVG) saw both its President/CIO Sajal Srivastava and CEO James Labe indirectly acquire shares totaling $737,479 each between December 22 and 26, 2025. The purchases were executed at prices ranging from $6.2863 to $6.3027 per share through TriplePoint Capital LLC, pursuant to pre-arranged Rule 10b5-1 trading plans. The transactions included identical patterns of acquisition: 26,900 shares on December 22, 31,910 shares on December 23, 26,756 shares on December 24, and 31,600 shares on December 26. TPVG currently trades at $6.39 with a P/E ratio of 7.5 and offers an impressive 14.56% dividend yield, having maintained dividend payments for 12 consecutive years.

TOP SELLS

Travere Therapeutics (NASDAQ:TVTX) Chief Research Officer William E. Rote sold 60,000 shares on December 24, 2025, at a weighted average price of $40.103 (ranging from $38.00 to $42.07), for a total value of $2,406,180. The transaction was executed under a prearranged 10b5-1 trading plan adopted on May 29, 2025, and involved shares from a stock option granted in February 2017. The sale comes as TVTX has experienced a 124% stock price surge over the past year, with shares trading near their 52-week high of $42.13.

Sionna Therapeutics, Inc. (NASDAQ:SION) Director Peter A. Thompson indirectly disposed of 33,356 shares at $44.55 on December 24, 2025, generating proceeds of $1,486,009. Following this transaction, Thompson still indirectly holds 3,561,655 shares of the company.

Reddit (NASDAQ:RDDT) Chief Technology Officer Christopher Brian Slowe sold 13,900 shares of Class A Common Stock on December 22, 2025, for approximately $3.2 million. The sales were executed across multiple transactions with prices ranging from $231.49 to $240.10. Currently trading at $234.65, Reddit stock has demonstrated strong momentum with a nearly 50% return over the past six months.

Wayfair (NASDAQ:W) Chief Executive Officer Niraj Shah sold 151,024 shares of Class A Common Stock on December 23 and 26, 2025, generating approximately $15.1 million. The transactions occurred at prices ranging from $98.11 to $102.32, amid Wayfair’s remarkable 133.65% stock price gain over the past year.

Workday, Inc. (NASDAQ:WDAY) ten percent owner David A. Duffield, through The David A. Duffield Trust, sold 118,279 shares of Class A Common Stock on December 23, 2025, for approximately $17.3 million. The sales occurred in multiple transactions with prices ranging from $214.32 to $216.88.

Why Insider Transactions Matter

Tracking insider buying and selling activities provides investors with valuable signals about potential company developments. Insiders possess unique insights into their companies’ prospects, and their trading decisions may reflect their confidence in future performance. While insider buying often suggests executives believe shares are undervalued or positive developments are forthcoming, selling can occur for various reasons including diversification, tax planning, or personal financial needs. Investors should consider insider transactions as just one factor in their broader investment research, looking for patterns rather than reacting to individual transactions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

This article highlights the most significant insider buying and selling activities disclosed on Monday, December 22, 2025, for US-listed companies.

Top Insider Buys

Coliseum Capital made substantial investments in MasterCraft Boat Holdings, Inc. (NASDAQ:MCFT), purchasing shares worth $2.65 million across three separate transactions. The buying activity spanned from December 18 to December 22, 2025, with 33,807 shares acquired at an average price of $19.34 on December 18, 76,000 shares at $19.79 on December 19, and 25,000 shares at $19.66 on December 22. The purchases were executed at prices ranging from $19.17 to $19.99 across the three-day period.

Suvretta Capital Management, LLC reported purchasing shares of Benitec Biopharma Inc. (NASDAQ:BNTC) between December 18 and December 22, 2025. The transactions, totaling $538,972, were executed at prices ranging from $11.24 to $12.08. Specifically, Averill Master Fund, Ltd. acquired 8,700 shares on December 18, 13,950 shares on December 19, and 16,650 shares on December 22, while Averill Madison Master Fund, Ltd. purchased 1,515 shares on December 18, 2,434 shares on December 19, and 2,892 shares on December 22.

SeaStar Medical Holding Corp (NASDAQ:ICU) Director Jennifer A Baird acquired 4,200 shares of common stock on December 19, 2025, at a price of $0.2351 per share, for a total value of $987. Following this transaction, Baird directly owns 36,200 shares of the company. This purchase comes as ICU shares have declined 87% over the past year and 18% in the last week alone, with the stock trading near its 52-week low of $0.23. Despite the company’s weak overall financial health score, ICU maintains a strong liquidity position with a current ratio of 3.66.

Andreessen Horowitz Funds, which hold beneficial ownership of more than 10% of Navan Inc. (NASDAQ:NAVN), reported purchasing a total of 702,395 shares of Class A Common Stock worth $9.3 million. The purchases were executed between December 17 and December 19, 2025, at weighted average prices ranging from $12.65 to $14.70. Specifically, 347,600 shares were acquired on December 17 at an average price of $12.65, 103,960 shares on December 18 at $13.61, and 240,835 shares on December 19 at $14.70. The stock currently trades at $15.11, above the purchase price range, despite falling 24.45% over the past six months.

Top Insider Sells

Precigen, Inc. (NASDAQ:PGEN) Director Randal J. Kirk reported selling 1,900,000 shares of common stock on December 22, 2025. The sales were executed at a price of $4.18 per share, totaling $7,942,150. The transactions involved multiple entities through which Kirk holds indirect ownership, including various LLCs and trusts. This sale comes as Precigen shares have surged 487% over the past year, with the stock currently trading at $4.38, slightly above Kirk’s sale price.

NVIDIA CORP (NASDAQ:NVDA) Director Mark A. Stevens sold 222,500 shares of common stock on December 19, 2025, for approximately $40 million. The shares were sold at a weighted average price of $180.168, with individual sales prices ranging from $179.960 to $180.505. Stevens also gifted 258,650 shares of NVIDIA common stock on December 18, 2025, without consideration. NVIDIA shares currently trade at $183.62, with the company valued at $4.46 trillion.

Snowflake Inc (NASDAQ:SNOW) Director Frank Slootman sold a total of 200,390 shares of common stock on December 18, 2025, for approximately $44.3 million. The sales were executed in multiple transactions with prices ranging from $217.43 to $223.214. The transactions included 3,744 shares at $217.43, 7,300 shares at $219.858, 31,710 shares at $220.505, 44,582 shares at $221.468, 107,574 shares at $222.595, and 5,090 shares at $223.214. Snowflake shares are currently trading at $226.84, up about 2% from the sale prices.

Broadcom (NASDAQ:AVGO) CEO Tan Hock E sold 130,000 shares of common stock on December 18, 2025, at a price of $326.02, for a total transaction value of $42,382,600. Following the transaction, Tan directly owns 482,836 shares and indirectly owns 595,638 shares by trust. The stock is currently trading at $341.38, approximately 4.7% higher than the transaction price. Broadcom, with a market capitalization of $1.62 trillion, has raised its dividend for 16 consecutive years and maintains an impressive 77.3% gross profit margin.

ATI Inc (NYSE:ATI) Executive Chairman Robert S. Wetherbee sold a total of 53,862 shares of common stock on December 18, 2025, for approximately $6.5 million. The sales occurred at weighted average prices ranging from $108.86 to $110.34 per share. Specifically, 6,507 shares were sold at an average price of $108.86, with individual prices ranging from $108.18 to $109.17, and an additional 47,355 shares were sold at an average price of $109.57, in a price range between $109.18 and $110.17.

Why Monitor Insider Transactions

Tracking insider buying and selling activities provides investors with valuable insights into how company executives and major shareholders view their own stock’s prospects. While insider buying often signals confidence in the company’s future performance, selling may occur for various reasons unrelated to company outlook, such as personal financial planning or diversification. Investors should consider insider transactions as just one factor in their investment decision-making process, alongside fundamental analysis, industry trends, and broader market conditions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.